Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Sarcoma 1

Conditions

Osteoporosis 5Breast Neoplasms 5Colorectal Neoplasms 4Vitamin D Deficiency 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Thyroid Neoplasms 2Lymphoma 2Leukemia 2Colonic Neoplasms 2Adenomatous Polyps 2Adenoma 2Thyroiditis 1Prostatic Neoplasms 1Polyps 1Polycystic Ovary Syndrome 1Pain 1Ovarian Neoplasms 1Osteosarcoma 1Obesity 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Hypocalcemia 1Hyperthyroidism 1Goiter 1Colonic Polyps 1Bone Diseases, Metabolic 1Arthralgia 1Aflatoxin Poisoning 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Calcium Carbonate × Clear all
NCT03612466 2022-10-14

A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy

Albert Einstein College of Medicine

Phase 1 Withdrawn
Sarcoma

Neoplasms, Osteosarcoma

NCT01052051 2019-07-24

CAPS

Creighton University

Phase 2/3 Completed
2,303 enrolled
Tumor-Agnostic

Neoplasms

NCT01677195 2016-04-19

RDMEACCS100

Texas Enterosorbents Incorporated

Phase 2 Completed
234 enrolled 7 charts

Aflatoxin Poisoning, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡